Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: Jul 22, 2026, 4:00 PM EDT
1.080
0.00 (0.00%)
Pre-market: Jul 23, 2026, 7:04 AM EDT

Biofrontera Revenue

Biofrontera had revenue of $10.08M in the quarter ending March 31, 2026, with 17.42% growth. This brings the company's revenue in the last twelve months to $43.20M, up 13.72% year-over-year. In the year 2025, Biofrontera had annual revenue of $41.71M with 11.75% growth.

Revenue (ttm)
$43.20M
Revenue Growth
+13.72%
P/S Ratio
0.32
Revenue / Employee
$459,585
Employees
94
Market Cap
13.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202541.71M4.38M11.75%
Dec 31, 202437.32M3.25M9.54%
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rockwell Medical67.68M
Aytu BioPharma56.60M
cbdMD19.98M
InMed Pharmaceuticals4.94M
TherapeuticsMD3.35M
BioXcel Therapeutics680.00K
Gelteq314.70K
Akanda258.08K
Revenue Rankings